Always looks like some are acting with inside knowledge.
Didn't rip it this week, sell off Friday but always poor on Friday.
Stock getting driven by enrolments so maybe even a strait resumption of trial will have little effect.
Still believe the number of deaths indicates that SSH has moved its recruitment to the almost dead. In which case the control arm will be an absolute mess of rehospitalisations, deaths, LVADs and transplants. Interesting to se if FDA reacts to this.
Germans seeking own reimbursement codes, whats happening there, some breakdown in relationship?
SHC Price at posting:
2.5¢ Sentiment: Buy Disclosure: Held
